Now I will hand the conference over to Interim President and CEO Niclas Sjöswärd and Interim CFO Christofer Carlsson. Please go ahead. Thank you, and good afternoon to everyone, and welcome to Arjo quarter one 2025 Earnings Call. With me here today, as you heard, I have Christofer Carlsson, our Interim CFO. We will give you some details on the quarter one report that we released an hour ago. The agenda looks as usual and includes a summary of activities and results from quarter one, the balance sheet items, and the outlook for 2025. Before we open up for questions, we intend to keep this call to an hour and finish no later than 4:00 P.M. CET. Next slide, please. We closed the first quarter in a solid way and could see how demand continued in the quarter, with stronger organic growth than in quarter four. We had continued strong momentum for our rental and service business, and now also supported by growth in our capital sales. We see improved market conditions in some more European countries, and North America stayed on good growth levels, and we closed the quarter with 3.4% organic net sales growth. In addition, as a positive sign for the rest of 2025, this net sales development is supported by an even stronger order intake growth. In our largest market, U.S., we continue to see a positive development, and this is probably related to a combination of our internal effort to create a more focused U.S. sales organization, as well as the financial situation and staff shortages are improving among our customers. In global sales, the net sales growth improved sequentially from quarter four. We are now seeing improving market conditions in some more European countries. We continue to see growth in the U.K. DACH and Benelux performed very well in the quarter, and it's encouraging to see that the bounce back in Benelux, which grew sales double-digit in quarter one. Our gross margin came in at 43.7%, a slight improvement versus last year's 43.5%. We continue to get support from lower material costs and price adjustments, while these improvements are partly offset by higher salary cost and currency headwind. For the rest of 2025, we will continue our work to drive efficiency focus throughout the value chain based on the plans that we have put in place, for example, within our supply chain organization. Our focus on price adjustments will obviously also remain there to secure compensation for mainly higher than normal salary inflation. On the OpEx side, we are seeing an increase mainly related to salary cost. We continued in the quarter to invest where we expect to drive profitable growth for the future. Adjusted EBITDA for the quarter was SEK 486 million versus SEK 502 million in quarter one last year, a reduction coming from currency headwind. Neutralized for currency headwind, the adjusted EBITDA would have increased with SEK 30 million, which is approximately a 6% improvement from the underlying business. Our operational cash flow came in at SEK 184 million, leading to a cash conversion of 41% for the quarter. For those knowing our business, you know that quarter one is, from a seasonality perspective, a weaker cash flow and cash conversion quarter, and it will gradually improve over the year. We continue to be committed to our 80% cash conversion target. In summary, we are delivering the first quarter of 2025 in a stable way. Our underlying business develops in a solid way, and we can see how our business model with capital, rental, and service is helping us to deliver stability in growth and underlying earnings trend. In addition to this, we see several important markets showing good signs of increased activity level and demand for our products and solutions. We now have two quarters in a row with higher order intake than sales, and we are building our order book stronger for the quarters to come. Next slide, please. Our North America business grew with more than 6% organically in the quarter. We had a continued very strong development in Canada, where service, rental, and capital all developed well. It is especially our long-term care business in Canada that is driving the growth with good profitability levels. In our largest market, U.S., we have a continued positive development also in this quarter. The growth in U.S. in the quarter was seen across our product categories. Rental and service continues to drive growth and is developing well. On the capital side, demand is coming back, and it's driven by our important patient handling category, while DVT was declining in the quarter, but should from next quarter have easier comp after the HCA customer account phase-out last year. Over to Western Europe and the rest of the world that make up the global sales region. In quarter one, this region grew with +1.4%, which is a sequential improvement from quarter four flat this growth development. In Western Europe, the situation seems to improve with higher activity level in the market and increased order intake and net sales for our capital products. Our important French market is still weak in quarter one sales, but order intake is growing, showing some positive signs for coming quarters also for this market. Countries with good demand and strong organic net sales growth in the quarter were, for example, Germany, the Netherlands, and Belgium. The U.K. is continuing to grow in quarter one, but at a lower level than the catch-up effect we could see in quarter four. Our service and rental business in Western Europe also developed well in the quarter. With improved sales growth and even higher order intake in Western Europe, we see good signs for the coming quarter in this region. Our business in the rest of the world had a negative organic net sales growth of -5.7% in the quarter, and this is due to a very tough comparison from last year when the growth was +11%. Our APEC region could not repeat last year's very strong sales in quarter one, where we had major deliveries of capital equipment in Singapore and Hong Kong. With this said, Australia is, however, standing out and growing double-digit in the quarter. India develops well also in this quarter, with good potential for further development in the coming quarters. Next slide, please. Our gross margin came in at 43.7%, a slight improvement versus last year of 43.5%. We continue to get support from lower material costs and price adjustments, while these improvements are partly offset by higher salary costs and currency headwind. In the quarter, the stronger growth in North America also contributed with positive geo-mix effect. We are, as before, working hard to mitigate the headwinds coming from increased salaries with continued long-term efficiency gained throughout the value chain, including solid focus on continued supply chain efficiencies. We need to continue to work on price adjustments as one part of the puzzle to mitigate further inflationary pressure. This work is now also intensified and aligned with any impact from the tariffs coming into play from quarter two. Next slide, please. Adjusted EBIT in quarter one declined versus last year only due to significant currency headwind. Neutralized for currency impact, EBIT would have been improving, showing a stable and improving underlying business. On the OpEx side, we are seeing an increase mainly related to salary cost. We continue to invest where we expect to drive profitable growth for the future. With this said, I'm not satisfied with the level the operating expenses increased in the quarter, and we will further accelerate efficiency activities for our operating expenses during coming quarters. We had a negative effect from revaluation of AR and AP of minus SEK 34 million in the quarter booked under other expenses. This was positive plus SEK 8 million in the same quarter last year. Adjusted EBITDA for the quarter was SEK 486 million versus the SEK 502 million in quarter one last year, a reduction coming from currency headwind. Neutralized for currency headwind, the adjusted EBITDA would have increased with SEK 30 million, which is approximately a 6% improvement from underlying business. Restructuring cost came in at minus SEK 40 million in the quarter, mainly related to changes in the executive team and our change of go-to-market approach in China, as well as some integration costs related to last year's acquisitions. Next slide, please. Here I hand over to our Interim CFO, Christofer Carlsson. Thank you, Niclas. Q1 followed the pattern that we usually see with lower operating cash flow due to some seasonal variance. Cash flow effect from working capital is typically negative in the first quarter, and in Q1 this year, it was SEK -180 million versus SEK 141 million in Q1 2024. The variance compared to Q1 2024 is primarily driven by an inventory build-up due to the good order book and upcoming rental investments. Working capital days decreased to 81 days in the quarter versus 84 days at year-end 2024. The working capital and closing balance is heavily impacted by the FX development, which has strengthened SEK, especially against USD. At constant FX rate at December 2024, the working capital days is plus four days in the quarter, amounting to 88 days by the end of Q1 2025, primarily driven by the inventory build-up. The lower profitability, together with the negative impact from working capital, gives an operating cash flow of SEK 184 million for the quarter versus SEK 256 million in Q1 2024. As an effect of this, cash conversion came in at 41.3% for the quarter versus 54.2% last year. As stated earlier, our cash flow is typically weaker in the first quarter of the year, and we're still aiming for the full-year target of 80% cash conversion in 2025. For your information, cash flow from investing activities was SEK -250 million versus SEK 141 million in Q1 2024. The increased investments are mainly related to investment in our rental fleet, which are SEK 42 million higher this quarter than last year. Next slide, please. Our net debt increased slightly during the quarter from SEK 4.2 billion in Q4 2024 to SEK 4.3 billion in Q1 2025. This increase is mainly attributed to lower cash flow in the period. Our financial net in the quarter is more or less flat compared to last year, but we have lower interest costs, which have been offset by reduced positive FX rate quarter- over- quarter. The interest net was also sequentially flat in Q1 versus Q4 2024. Currently, we have lower interest rates versus a year ago, and if the interest rates continue on the same level, we will see improvements year-over-year in both Q2 and Q3. We expect our net debt to decline in the coming quarters. Our cash position remains strong. Our leveraged net debt to adjusted EBITDA had a normal seasonal increase and came in at 2.1 versus 2.0 at year-end. The equity rate came in unchanged at 51.2% versus the year-end. Next slide, please. With the current year political landscape, we also want to take the opportunity to briefly clarify our exposure to potential U.S. tariffs. One important message is that 40% of our U.S. revenue is coming from service and rental business, which in nature is domestic and not impacted directly by tariffs. To be clear, when we're talking about service business in this context, it is only service labor business included. Spare part sales are not included in the 40%. The capital sales and spare part sales are coming from product produced in our factories outside the U.S. The vast majority is coming from Poland, 20%, the Dominican Republic, 20%, and Canada, 10%, followed by China and the U.K. with 5% respectively. We are working actively with many different mitigation activities, which includes, but are not limited to, price increases to customers, change flows with our manufacturing footprint, and other changes to our operational setup. I hand it back to you, Niclas. Thank you, Christofer. I'm very happy to be able to share that we have now officially launched our Maxi Move 5 floor lift, which is a key product for our important patient handling category. This new generation of one of Arjo's best-selling products enables safe and efficient patient transfers. New features include the new Arjo Motion Assist, operated via touch sensors and reacting to the caregiver push, pull, and other motions to enable efficient and controlled and intuitive transfers with minimal effort for the caregiver. A recent independent study showed that the Maxi Move 5 reduces the accumulated forces required by the caregiver to complete a patient transfer by almost 70% compared to competitor devices. We are launching this lift in approximately 40 countries during this year, and it means that we now have two global launches in two important product categories in 2025 since we launched a new premium bath system, Symbliss, earlier this year. During the H2 of this year, we will continue and we will have one more launch, a new product in our important pressure injury prevention category. Next slide, please. Our outlook for 2025 is that the organic net sales growth will be well within the group's target interval of 3%-5%. With that, I would like to summarize today's telco. We see continued healthy growth in quarter one with a strengthened order book and gross margin expansion. Our profitability is quite significantly impacted by negative currency effects, but the underlying business continues to develop in a good way. We strengthen our market positions with two new products brought to market, something that we are really excited about and will increase our discussions with customers going forward. We monitor the geopolitical situation closely and are preparing a number of measures to limit impact from U.S. tariffs. Finally, our outlook remains unchanged for 2025. With that, we can open up for questions. Moderator, please go ahead. If you wish to ask a question, please dial pound key five on your telephone keypad to enter the queue. If you wish to withdraw your question, please dial pound key six on your telephone keypad. The next question comes from David Johansson from Nordea. Please go ahead. David Johansson from Nordea, your line is now unmuted. Please go ahead. Okay. Hi, good afternoon. Thank you for taking my questions. I have three, please. First on the tariff situation, which I think is one of the major topics here. It seems to be something wrong with the line there, but good afternoon and thank you for taking my questions. I have three, please. First on the tariff situation, which I think is one of the major topics here. I think given what we know today and your expectations for pricing and the product mix and so on, is this deferring from your expectations on gross margin improvements as we look to the full year? If you could walk us through that and the impact of that, maybe some of the offsets. I think you talked about some flexibility to adapt to the current conditions and to what extent are you able to mitigate and what are examples of some of those measures. I'll leave it there for my first one. Thank you. Yeah. Okay. Thank you, David. Yeah, of course, it's a major topic for us as well, the tariffs. We tried to show the exposure and the flows here on one of the slides that we presented. I think that's the basis, of course, for how we work going forward. We will and have already initiated price discussions with our customers in the U.S. That will be one important part to mitigate. We also see opportunities in how we route and the flow of our products from our global manufacturing footprint. Without going into any details on how we do that, it's really those two. One is to flow the products through our footprint in the most efficient way. The other one is price adjustments to customers. Of course, in addition to that, we're in an uncertain world. I also think we should recognize that the tariff levels seem to change over time, etc. We will, of course, also be more careful with our costs going forward in general. On the GP side, we do not guide on that, as you know. Our target is, of course, or ambition is, of course, to mitigate as much as possible with activities like I mentioned. We do not hear you, David, if you are asking one more question. Okay. Perhaps a follow-up on that and a question on the overall cost base. Would you be able to provide a more general margin update, I think, for the business? I'm very sorry, David. You are breaking up all the I'm very sorry, David. You are breaking up all the time. It's quite difficult to follow. Question comes from David Johansson from Nordea. Please go ahead. Johansson from Nordea, your line is now unmuted. Please go ahead. Question comes from Rickard Anderkrans from Handelsbanken. Please go ahead. Hi. Hope you can hear me. I have a few questions, please. Could you please provide any insights into the current hospital CapEx environment in your key product categories in key markets? We've seen some increasingly cautious outlook and wording on the capital side in general. How are you feeling about the outlook for the year and the coming quarters here on the capital side? Thank you. Yeah. As I mentioned from my examples of the development in North America and Europe specifically, we see it quite positively, actually. We have, during the quarter, stronger order intake than deliveries for capital. We are also growing on the delivery side. It is a positive momentum. Some of the markets that we have been concerned about before and seen weaker demanding is actually moving in the right direction, where France is picking up in the order intake. Netherlands is not only having stronger order intake, but also growing the sales, two markets we have mentioned before. In addition to that, the U.K. turned around already in quarter four. I think here we see positive signs. Since the order book is stronger, even stronger, we see it forward-looking as well. In North America, we built a fantastic order book for capital in Canada during quarter four. It is continuing to deliver on that in quarter one and it will continue. In the U.S., as I mentioned, we also now see order intake growth in capital as well. In general, we do not see that cautiousness. Rather, we see in quarter one a more brighter picture. All right. That's encouraging. It would be interesting to hear and understand a bit more on the magnitude and phasing of the accelerated cost reduction initiatives. Maybe you can elaborate a little bit on what areas you will target for cost containment here that you mentioned in the report? Yeah. When it comes to the acceleration in the operating expenses that I mentioned, we went into this year with good plans. I actually had one slide in the quarter four report where I talked about our programs around improving indirect spend, improving our processes through more IT harmonization, and also look at new ways of working and new ways of organizing. We have solid plans for the year, but as I said, I'm not satisfied with how we developed short-term in quarter one. Of course, we will push those improvement projects further, as I mentioned. In addition to that, we also need to be careful with rehiring and take a slower pace in activity levels that we have in the company. You asked for a magnitude. I will not give that. Of course, what we are aiming at here is to come back to a continued trend of where we have leverage in our operating expenses, meaning that we year-over-year improve OpEx to sales ratio. All right. And then a final question. Do you think it's, as things stand with tariffs and FX, just trying to get expectations sort of on a reasonable level, I guess it's reasonable to have a base case which assumes declining adjusted EBIT margin for the full year to capture these headwinds? Is there any reason to assume that the margin will be able to expand given the landscape out there? Our ambition is, of course, to mitigate all headwinds, even if they are external factors. In quarter one, the headwinds was especially currency so significant, we could not do that on that short notice. We will focus this year to do everything we can, of course. I think I would not guide here and now for something different. Absolutely not. The tariffs is fluid. We do not know how that will develop. We know what we have now, but we do not know what we have in a month. I think that would also be premature. When it comes to the revaluation of the AP/AR, I mean, that is a one-time impact. If the currency stays on this level, it is not coming again. If it improves, we get it back, you can say. I think it's too early to draw any conclusion on the full year right now. All right. Fair enough. Thank you for taking my questions. Question comes from Sten Gustafsson from ABG Sundal Collier. Please go ahead. Thank you. Good afternoon, everyone. Coming back to the tariff discussion here, I appreciate the information you have provided on the slide there. I fully understand that it's a lot of moving parts here. Based on what we know today in terms of where tariff rates are, how would this, and assuming that it would, we do not know how long it will stay in place, but we can assume it will remain for some time. Based on the information you have today, how would this impact the gross margin for the full year? That would be my first question. The second question is regarding the OpEx. I mean, looking at selling expenses, for example, how much of the increase from quarter one last year would you say is FX-related on the selling expenses line? Given the fact that the Swedish krona now has strengthened, is it fair to assume that this will come down, the selling expense line, the coming quarters? That would be my second question. Thank you. Yeah. Thank you, Sten. On the tariffs, we will not guide on a GP margin impact because we are mitigating with everything we can. I think that will just give the wrong information, I think. We are doing everything we can. Let's see how much price we can get out to customers, and let's see how much rerouting in our manufacturing footprint we can do. We have not given up our ambition for the year, not at all. On the OpEx side and currency impact, maybe I should ask Christofer if you have a take on that. Yes. I mean, when we're talking about translation of our P&L numbers, we still have average rates that are actually higher than a year ago. If you look isolated in March, you have the opposite. You will see a decrease in translation. We have a smaller negative impact year to date in the quarter one due to the translation rates compared to a year ago on the OpEx side. It is a small number. Yeah. I do not know if I understand the smaller. You said the main reason for the increase was FX. I mean, what is the sort of the organic increase in OpEx then, if you take it that way? The major FX components in OpEx is actually in the other operating income. So it's nothing in the selling admin expenses itself. It's the revaluation of accounts payable and accounts receivable that has been hitting our EBIT result in this quarter. Yeah. Sure. No. I meant on the selling expense line and the admin expense. What? SEK 6 million in translation effect on OpEx. It is a fairly small number. Sure. That I understand. On, let's say, the selling expense line, what's the organic increase? I think we can come back on that. For selling admin and R&D, what we call operating expenses on that line, it's slightly over 4% organic increase, which is, as I said, something I'm not happy with. We. The organic growth in. Okay. Thank you very much. Thank you. Thank you. Question comes from Kristofer Liljeberg from Carnegie. Please go ahead. Yeah. Sorry, but I have to come back to cost development here. If we start with the salary increases, how much has that been? We do not go down to that detail. Our operating expenses are increasing a little bit over 4%. That is on a level where we do not get the leverage we want. That is what I said I am not happy with. That is what we will address for the quarters to come. It is mainly related to salary increases. Okay. Yeah. It seems, yeah, it seems it could not have been any positive effect from the cost savings initiatives. I think we all understand you are not happy with that. Maybe could you explain why you have not achieved any savings in Q1? The reason for that, in what quarter do you expect to achieve this, and the confidence in actually achieving this? Thank you. Yeah. No, but the projects that should drive improvements are moving on well. I have confidence that we will deliver it. The timing has been later than I wanted. I wanted to see impact in quarter one. We did not see that. There could be projects that you are running are sometimes taking a little bit more time. That is what we have seen here. They are continuing. In addition to that, we will take measures internally to also be much more restrictive with hirings, etc. We will also be more careful with cost in addition to our sort of process improvement activities. We will see improvements in quarter two and all those. Could you maybe, do you expect improvements in quarter two? Is that what you're saying? Yeah. Starting from quarter two with a lower percentage increase and a better OpEx to sales ratio. Can you hear me? Yes, Kristofer, do you hear me? Okay. Thank you. Question comes from Mattias Vadsten from SEB. Please go ahead. I don't know what's going on. Yeah, I hear you. Thank you. Hi. Hope you can hear me well. I have three questions as well. First, want to pick up on the recent questions on OpEx. First, is the restructuring line looks a bit high? Maybe if you can guide to what levels you're expecting this to be established in quarter two and maybe for the following quarters. Also, did I catch you correctly here that you anticipate OpEx to sales will fall year-over-year in Q2 and for the rest of the year? That's the first one. Yeah. To start with, when it comes to the restructuring, they were on a normal high in quarter one due to the changes in the executive team. As we have been seen in our information, Joacim Lindoff left as CEO, and we had one more change in the executive team. In addition to that, we also had restructuring cost for changing our go-to-market model in China and then some smaller amounts for our integration work with acquisitions we did last year. That is higher than normal. Going forward, we do not have any unusual restructuring activities planned. It is more back to a normal run rate that you have seen from us before. On the other one, what I said to Christofer was that we expect already in quarter two to come back to sequentially a lower OpEx. On the question around OpEx to sales, if that is anticipated to fall year-over-year. Yes. When it comes to quarter two, what I mean is that our organic cost increase in OpEx will come back to levels we have seen before, meaning around 3.5% or something like that, and not on the about 4% that we saw in quarter one. That is what I mean, that it will be sequentially lower. Thank you. Good. I try with the next question now. I mean, we remember the weakness in some of the Western European markets last year, especially in the H2 on the capital side. Just if you would agree that the comp is much easier here for the remainder of the year compared to what we saw in quarter one. I guess also the comparison quarter, by the looks of it, is easier also for the rest of the world. With this in mind, is it reasonable to expect quarter one to have been the lowest growth quarter during 2025 do you believe? That is the second one. I think we can say like this. Yes, quarter one had a difficult comp. I think I've said that before. We are very happy to see that we were able to grow 3.4% versus a difficult comp. Also, quarter two last year was good. We should remember that. Quarter three was weaker. I think that we should have that in mind at least. Okay. Good. I just wondered if you have—sorry if you mentioned this before—but if you have an estimate on the FX impact on the EBIT margin for the full year if current spot rates remain. That's the last one. Thank you for taking my question. Yeah. No, we do not have a number on that. What I said before is just that the big negative impact in quarter one from currency came from revaluation of AP/AR. We should just remember that if the currency stays on the same level, that was a one-time hit, and it will not be repeated. If it is improving, it could also come back. I think that was the main point here. We will not guide on an EBIT impact for full year. Reminder, if you wish to ask a question, please dial pound key five on your telephone keypad. No more questions at this time. I hand the conference back to the speakers for any closing comments. Okay. Thank you. Thank you, everyone, for listening in. My understanding is that there's been a long delay between questions and answers in this Q&A session. I apologize for that. Just to summarize, as I started off, we see that we started quarter one in a good way, where our organic net sales growth came in at 3.4% compared to a good last year. Our order intake is even stronger in the growth than that. We are continuing to build our order book, which is something we see as a positive sign for the rest of the 2025 growth development. Neutralizing for currency headwind, we are continuing to improve our earnings trend. We are happy to now launch our important Maxi Move 5 lift to our customers. Thank you very much for listening in. Bye.